Daniel L Johnson

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Venues

Biomedicines

Cancers

Current oncology (Toronto, Ont.)

PLoS genetics

University of Tennessee Health Science Center

Arkansas State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Tennessee Health Science Center May 01 2015

United States

Director of Molecular Informatics :: Office of Research

Caraway Medical Center Aug 01 2005 - May 15 2015

United States

Systems Adminstrator / Database Administrator :: IT

Arkansas State University May 01 2009 - Apr 30 2015

United States

Lab Manager / Temp Instuctor :: Molecular Biosciences

Education History

Arkansas State University Aug 01 2009 - May 01 2015

United States

PHD :: Molecular Biosciences

Arkansas State University Sep 01 2005 - Aug 01 2009

United States

MSC :: Computer Science

Arkansas State University Sep 01 2005 - Jul 01 2009

United States

MSC :: Mathematics

Arkansas State University Aug 01 2000 - Aug 01 2005

United States

BSC :: Computer Science

Arkansas State University Aug 01 2000 - Aug 01 2005

United States

BSC :: Mathematics

Publications

Farhan Khan, Obianuju Mercy Anelo, Qandeel Sadiq, Wendy Effah, Gary Price, Daniel L Johnson, Suriyan Ponnusamy, Brandy Grimes, Michelle L Morrison, Jay H Fowke, D Neil Hayes, Ramesh Narayanan
Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer. Biomedicines 11 (3) (2023)
Farhan Khan, Obianuju Mercy Anelo, Qandeel Sadiq, Wendy Effah, Gary Price, Daniel L Johnson, Suriyan Ponnusamy, Brandy Grimes, Michelle L Morrison, Jay H Fowke, D Neil Hayes, Ramesh Narayanan
Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer. Biomedicines 11 (3) (2023)
Raisa I Krutilina, Hilaire Playa, Danielle L Brooks, Luciana P Schwab, Deanna N Parke, Damilola Oluwalana, Douglas R Layman, Meiyun Fan, Daniel L Johnson, Junming Yue, Heather S Smallwood, Tiffany N Seagroves
HIF-Dependent CKB Expression Promotes Breast Cancer Metastasis, Whereas Cyclocreatine Therapy Impairs Cellular Invasion and Improves Chemotherapy Efficacy. Cancers 14 (1) (2021)
Feng Liu-Smith, Chi-Yang Chiu, Daniel L Johnson, Phillip Winston Miller, Evan S Glazer, Zhaohui Wu, Matthew W Wilson
The Sex Differences in Uveal Melanoma: Potential Roles of EIF1AX, Immune Response and Redox Regulation. Current oncology (Toronto, Ont.) 28 (4) (2021)
Hongfeng Chen, P Winston Miller, Daniel L Johnson, R Nicholas Laribee
The Ccr4-Not complex regulates TORC1 signaling and mitochondrial metabolism by promoting vacuole V-ATPase activity. PLoS genetics 16 (10) (2020)
Iram Fatima, Ikbale El-Ayachi, Hilaire C Playa, Jackelyn A Alva-Ornelas, Aysha B Khalid, William L Kuenzinger, Peter Wend, Jackelyn C Pence, Lauren Brakefield, Raisa I Krutilina, Daniel L Johnson, Ruth M O'Regan, Victoria Seewaldt, Tiffany N Seagroves, Susan A Krum, Gustavo A Miranda-Carboni
Simultaneous Multi-Organ Metastases from Chemo-Resistant Triple-Negative Breast Cancer Are Prevented by Interfering with WNT-Signaling. Cancers 11 (12) (2019)

Daniel L Johnson.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel L Johnson